BUSINESS● LOW6d ago · Oct 7, 2026, 1:00 PM
Merck’s injectable Keytruda barred in Europe as Halozyme wins injunction
Seeking Alpha Tech · western europe
Merck's injectable drug Keytruda has been barred in Europe following an injunction won by Halozyme. This development impacts the pharmaceutical market and Merck's product availability in the region.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoDoes Hong Kong’s economy serve the people or profit?South China Morning PostBUSINESS50m agoChina's exports likely grew by double-digits in SeptemberCNBC